← Eichor
Condition: Neoplasms Glandular And Epithelial Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Neoplasms Glandular And Epithelial

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750The PREDICT Registry:
Phase N/A · 30 location(s) · PreludeDx · NCT03448926Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
Phase 3 · 1 location(s) · Severance Hospital · NCT05439278Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recu
Phase 3 · 1 location(s) · Chengdu CoenBiotech Co., Ltd · NCT06241755Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06725576A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · 193 location(s) · Janssen Research & Development, LLC · NCT06319820IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Phase 1 · 2 location(s) · TuHURA Biosciences, Inc. · NCT06940440Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Phase N/A · 1 location(s) · Mayo Clinic · NCT06401889A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06405425Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Phase 3 · 19 location(s) · Gruppo Oncologico Italiano di Ricerca Clinica · NCT04996017tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrel
Phase N/A · 1 location(s) · National Cancer Centre, Singapore · NCT05517135The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06118723Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT07177794Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Phase 2 · 31 location(s) · German Society for Pediatric Oncology and Hematology GPOH gG · NCT06019130SwissNET - a Registry for Neuroendocrine Tumours in Switzerland
Phase N/A · 55 location(s) · Insel Gruppe AG, University Hospital Bern · NCT01039922A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,
Phase 2 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06475300Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer
Phase 2 · 1 location(s) · Fudan University · NCT05010681Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC
Phase 3 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05608200A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · 40 location(s) · Pfizer · NCT05355701Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT05023265TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Ph
Phase 2 · 1 location(s) · Fei Gao · NCT05882370Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta
Phase 2 · 88 location(s) · National Cancer Institute (NCI) · NCT06029270Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT01649830Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT05911230Early vs Delayed Intravesical Blad-Care During BCG Therapy
NA · 1 location(s) · BLAD-HYA Group · NCT07495072A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT07003542A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocel
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05394259A Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemoth
NA · 1 location(s) · The Second Affiliated Hospital of Hainan Medical University · NCT07546383Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Phase 3 · 1 location(s) · Fudan University · NCT05717803Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Phase 3 · 11 location(s) · NX Development Corp · NCT05804370
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.